The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
A. R. Subbalakshmi, S. Sahoo, P. Manjunatha, S. Goyal, V. A. Kasiviswanathan, Y. M, S. R, I. McMullen, J. Somarelli, M. K. Jolly
Abstract
Epithelial-mesenchymal plasticity (EMP) involves bidirectional transitions between epithelial, mesenchymal and multiple intermediary hybrid epithelial/mesenchymal phenotypes. While the process of epithelial-mesenchymal transition (EMT) and its associated transcription factors are well-characterised, the transcription factors that promote mesenchymal-epithelial transition (MET) and stabilise hybrid E/M phenotypes are less well understood. Here, we analyse multiple publicly-available transcriptomic datasets at bulk and single-cell level and pinpoint ELF3 as a factor that is strongly associated with an epithelial phenotype and is inhibited during EMT. Using mechanism-based mathematical modelling, we also show that ELF3 inhibits the progression of EMT, suggesting ELF3 may be able to counteract EMT induction, including in the presence of EMT-inducing factors, such as WT1. Our model predicts that the MET induction capacity of ELF3 is stronger than that of KLF4, but weaker than that of GRHL2. Finally, we show that ELF3 levels correlates with worse patient survival in a subset of solid tumor types, suggesting cell-of-origin or lineage specificity in the prognostic capacity of ELF3.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- KLF4 induces Mesenchymal-Epithelial Transition (MET) by suppressing multiple EMT-inducing transcription factors
A. R. Subbalakshmi, S. Sahoo, … M. K. Jolly·CancersPeer-reviewed·Oct 13, 2021
- E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial-mesenchymal transition in bladder carcinoma
K. Gondkar, K. Patel, … P. Kumar·bioRxiv·Dec 14, 2018
- Systems-level analysis identifies IRF6 as an inhibitor of epithelial-mesenchymal transition
Ayalur Raghu Subbalakshmi, Aditya Agrawal, … Mohit Kumar Jolly·Journal of Biological EngineeringPeer-reviewed·Jun 14, 2026
- A computational systems biology approach identifies SLUG as a mediator of partial Epithelial-Mesenchymal Transition (EMT)
A. R. Subbalakshmi, S. Sahoo, … M. K. Jolly·bioRxiv·Sep 3, 2020
- NFATc acts as a non-canonical phenotypic stability factor for a hybrid epithelial/mesenchymal phenotype
A. R. Subbalakshmi, D. Kundnani, … M. K. Jolly·bioRxiv·Apr 18, 2020
- Population heterogeneity in the epithelial to mesenchymal transition is controlled by NFAT and phosphorylated Sp1
Russell A. Gould, David M. Bassen, … Jonathan Talbot Butcher·PLoS Computational BiologyPeer-reviewed·Dec 27, 2016